Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sun Pharma Advanced Research Co. Ltd.

www.sunpharma.in

Latest From Sun Pharma Advanced Research Co. Ltd.

Keeping Track: US Approvals For Xpovio And Xembify Highlight Short Holiday Week

The latest drug development news and highlights from our US FDA Performance Tracker.
Approvals Drug Review

China Beckons: Sun Joins Indian Firms Priming For Larger Presence

Evolving regulations and emerging opportunities appear to have put China firmly on the radar of several frontline Indian firms. Sun Pharma is the latest to join those seeking a larger play in the Asian market.
Commercial Strategy

Purple Patch For Pharma/Biotech R&D As NAS Launches Reach Record High

The pharma and biotech industries enjoyed their most productive year since the turn of the century in terms of number of novel products launched worldwide in 2018.

Launches Analysis

Asia Deal Watch: Athenex Changes Mind, Gets Back Chinese Rights To Actinic Keratosis Candidate

Following a positive Phase III data readout for KX2-391, Athenex requests dissolution of its recent deal conferring rights to the drug in China to Chongqing Jingdong Junzhuo. TaiwanJ licenses Asian rights outside its home market for JK-122 to Newsoara.
Asia Pacific Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Nanotechnology, Chips, etc.
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Respiratory, Pulmonary
  • Alias(es)
  • SPARC
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Sun Pharma Advanced Research Co. Ltd.
  • Senior Management
  • Anil Raghavan, CEO
    Sudhir V Valia, CFO
    T. Rajamannar, PhD, EVP, R&D
  • Contact Info
  • Sun Pharma Advanced Research Co. Ltd.
    Phone: 22 6645 5645
    17B Mahal Industrial Estate
    Mahakali Caves
    Mumbai, 400-093
    India
UsernamePublicRestriction

Register